CDC Advisers Reconsider Longstanding Hepatitis B Vaccine Policy for Infants

December 6, 2025 - 02:43

In a controversial move, the vaccine advisory group reversed a recommendation for universal immunization of newborns intended to protect them from a virus that attacks the liver. This decision marks a significant shift in public health policy, as the hepatitis B vaccine has been routinely administered to infants for decades.

The advisory group's vote has sparked debate among health professionals and parents alike, with many expressing concern over the potential implications for infant health. Hepatitis B is a serious viral infection that can lead to chronic liver disease and liver cancer, making vaccination during infancy crucial for long-term health outcomes.

Supporters of the reversal argue that the current approach may not be necessary for all infants, citing improved screening and treatment options for mothers with hepatitis B. However, critics warn that this change could leave vulnerable infants unprotected, raising fears of increased infection rates. The decision highlights the ongoing discussions around vaccination policies and their impact on public health.